Emanuele Crupi
@emanuele_crupi
Followers
170
Following
1K
Statuses
159
Medical Oncology Resident Fellow at IRCCS San Raffaele, Milan #GUoncology #bladdercancer #immunotherapy #precisionmedicine
Milano, Lombardia
Joined November 2022
RT @IBCG_BladderCA: Introducing Voices of the Steering Committee for the IBCG Center for Patient-Centric Care Initiatives! First up: Dr.…
0
10
0
RT @urologysummit: Role of Hb to RDW ratio in metastatic RCC patients treated with first-line immunotherapy combinations. A promising progn…
0
5
0
RT @AndreaNecchi: PARP inhibitors Cv safety in full @BrigidaMaiorano @vale_tateo @Anto_cigliola @CMercinelli @MyUniSR @SanRaffaeleMI @neera…
0
14
0
RT @UroDocAsh: As our first 'effort' it is our privilege to announce the BCAN 2025 New Faces of Bladder Cancer Survey. The survey aims to…
0
10
0
RT @UroDocAsh: The IBCG Board is excited to announce the new IBCG Center for Patient-Centric Care Initiatives! This global effort will br…
0
23
0
RT @montypal: To my #MedicalOncology colleagues: If you are looking for a terrific way to catch up on key issues in #RadiationOncology, che…
0
8
0
RT @tompowles1: A personalised cancer RNA vaccine (cevumeran) +/- atezolizumab (n=210) in pretreated advanced tumors showed neoantigen spec…
0
27
0
RT @MattGalsky: Please support Alliance A032103 to define the role of ctDNA-based adjuvant therapy decision making in #BladderCancer. @ALLI…
0
21
0
RT @PavlosMsaouel: 1/5 Thrilled to share in @NatureComms the clinical outcomes and scRNA-seq correlatives our phase I triplet immunotherapy…
0
47
0
Another outstanding paper made by an incredible team. Kudos to @Markuseckstein3 , @niklas_kluemper and team. A must read! @oncodaily
Link in the initial post is broken !
1
1
6
@GiorgioBre @oncodaily MRI is the most accurate tool for response evaluation, offering a high negative predictive value for residual MIBC (93%–98%). Substantial interreader agreement supports nacVI-RADS; however, variations in readers' performance underline the challenges.
0
0
2
@mjmoussa_ @BladderCaJrnl @BladderCancerUS @kovalenkojuls @GFallara_MD @DanieleRaggi83 @DocMattCampbell @urotoday You are doing an amazing job MJ, no doubt you'll shine everyday brighter! Deeply honoured to call you my friend and can't wait to work on more collaborative projects together 💪🏻
0
0
2
RT @LauraBukavinaMD: Serial ctDNA monitoring in met RCC Patients with serial ctDNA - or clearance had a 3.2x ⬇️ risk of progression during…
0
14
0
RT @drenriquegrande: ⚡️ On @JCOPO_ASCO - Assessing Nectin-4 as a Predictive Biomarker in Urothelial Carcinoma and Other Genitourinary Malig…
0
11
0
RT @mjmoussa_: 🔥NOW in @BladderCaJrnl of @BladderCancerUS👉Can Combining ICIs w/ Antiangiogenic Agents Revive Antiangiogenic Therapy in Adva…
0
15
0